Suppr超能文献

甲状腺手术中使用引流管是否切实可行?一项前瞻性随机干预研究。

Is the use of a drain for thyroid surgery realistic? A prospective randomized interventional study.

作者信息

Deveci Ugur, Altintoprak Fatih, Sertan Kapakli Mahmut, Manukyan Manuk Norayk, Cubuk Rahmi, Yener Nese, Kebudi Abut

机构信息

General Surgery Department, School of Medicine, Maltepe University, 34843 Istanbul, Turkey.

出版信息

J Thyroid Res. 2013;2013:285768. doi: 10.1155/2013/285768. Epub 2013 May 30.

Abstract

Background. The use of a suction drain in thyroid surgery is common practice in order to avoid hematomas or seromas. The aim of this study was to determine the efficacy of routine drainage after thyroid surgery. Methods. In this prospective randomized trial, 400 patients who underwent either a total thyroidectomy or lobectomy for thyroid disorders were randomly allocated to either the nondrainage (group 1) or the drainage (group 2) group. The volume of fluid collection in the operative bed, postoperative pain, complications, and length of hospital stay were then recorded. Results. Both groups were homogeneous according to age, gender, thyroid volume, type of procedure performed, and histopathological diagnosis. After assessment by USG, no significant difference was found between the groups in the fluid collection of the thyroid bed (P = 0.117), but the length of hospital stay was significantly reduced in group 1 (P = 0.004). Conclusions. In our experience, the use of drain for thyroid surgery is not a routine procedure. However, it should be used in the presence of extensive dead space, particularly when there is retrosternal or intrathoracic extension, or when the patient is on anticoagulant treatment. This trial was registered with clinical Trials.gov NCT01771523.

摘要

背景。在甲状腺手术中使用引流管是为避免血肿或血清肿的常见做法。本研究的目的是确定甲状腺手术后常规引流的效果。方法。在这项前瞻性随机试验中,400例因甲状腺疾病接受全甲状腺切除术或甲状腺叶切除术的患者被随机分配至无引流组(第1组)或引流组(第2组)。随后记录手术床的积液量、术后疼痛、并发症及住院时间。结果。根据年龄、性别、甲状腺体积、所施行手术类型及组织病理学诊断,两组具有同质性。经超声检查评估,两组甲状腺床的积液量无显著差异(P = 0.117),但第1组的住院时间显著缩短(P = 0.004)。结论。根据我们的经验,甲状腺手术使用引流管并非常规操作。然而,在存在广泛死腔的情况下应使用引流管,特别是当有胸骨后或胸腔内延伸,或患者正在接受抗凝治疗时。本试验已在ClinicalTrials.gov注册,注册号为NCT01771523。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9293/3683501/2eddbefa1202/JTR2013-285768.001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验